Journal for ImmunoTherapy of Cancer (Nov 2020)
175 A Fas-4–1BB immunomodulatory fusion protein converts a pro-death to a pro-survival signal, enhancing T cell function and efficacy of adoptive cell therapy in murine models of AML and pancreatic cancer
Abstract
No abstracts available.